Rosiglitazone Decreases Bone Mineral Density and Increases Bone Turnover in Postmenopausal Women With Type 2 Diabetes Mellitus

John P. Bilezikian; Robert G. Josse; Richard Eastell; E. Michael Lewiecki; Colin G. Miller; Margaret Wooddell; Allison R. Northcutt; Barbara G. Kravitz; Gitanjali Paul; Alexander R. Cobitz; Antonio J. Nino; Lorraine A. Fitzpatrick

首页> 外文期刊>The journal of clinical endocrinology and metabolism >Rosiglitazone Decreases Bone Mineral Density and Increases Bone Turnover in Postmenopausal Women With Type 2 Diabetes Mellitus

【24h】

Rosiglitazone Decreases Bone Mineral Density and Increases Bone Turnover in Postmenopausal Women With Type 2 Diabetes Mellitus

机译：罗格列酮降低了2型糖尿病绝经后妇女的骨矿物质密度并增加了骨周转率

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Context:Postmenopausal status and type 2 diabetes mellitus (T2DM) are independent risk factors for fractures. An increased fracture risk has been observed with rosiglitazone (RSG), a thiazolidinedione, in patients with T2DM.

机译：背景：绝经后状态和2型糖尿病（T2DM）是骨折的独立危险因素。罗格列酮（RSG），噻唑烷二酮对T2DM患者的骨折风险增加。

著录项

来源
《The journal of clinical endocrinology and metabolism》 |2013年第4期|共10页
作者
John P. Bilezikian; Robert G. Josse; Richard Eastell; E. Michael Lewiecki; Colin G. Miller; Margaret Wooddell; Allison R. Northcutt; Barbara G. Kravitz; Gitanjali Paul; Alexander R. Cobitz; Antonio J. Nino; Lorraine A. Fitzpatrick;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类代谢病;
关键词

相似文献

外文文献
中文文献
专利

1. Association of osteoglycin and FAM5C with bone turnover markers, bone mineral density, and vertebral fractures in postmenopausal women with type 2 diabetes mellitus [J] . Tanaka Ken-ichiro, Kanazawa Ippei, Kaji Hiroshi, Bone . 2017,第期

机译：骨胶蛋白和FAM5C与骨质周转标记，骨矿物质密度和椎骨骨折患者患有2型糖尿病
2. Increased bone density and decreased bone turnover, but no evident alteration of fracture susceptibility in elderly women with diabetes mellitus. [J] . Gerdhem P, Isaksson A, Akesson K, Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA . 2005,第12期

机译：老年糖尿病妇女的骨密度增加和骨转换减少，但骨折敏感性没有明显改变。
3. Association between serum levels of bone turnover markers and bone mineral density in men and women with type 2 diabetes mellitus [J] . Chenhe Zhao, Guangwang Liu, Yao Zhang, Journal of clinical laboratory analysis. . 2020,第4期

机译：2型糖尿病男女骨周转标志物和骨质矿物密度的血清水平与骨质矿物密度
4. Association of bone mineral density and mammographic breast density in premenopausal and postmenopausal Malaysian women: Study on women with and without breast cancer [C] . Norhayati Mohd Zain, Vengkatha Priya Seriramulu, Kanaga Kumari Chelliah, International Conference on Bio-engineering for Smart Technologies . 2016

机译：绝经前和绝经后马来西亚女性的骨矿物质密度与乳房X线照片乳房密度的关系：有无乳腺癌的女性研究
5. The relationship of vitamin D and selected nutrient intakes, sex hormone binding globulin and markers of bone turnover to bone mineral density in exercising and non-exercising postmenopausal women taking or not taking HRT. [D] . Sparks, Patricia Lynne. 2001

机译：在接受或不接受HRT的运动和非运动绝经后妇女中，维生素D与选定的营养摄入量，性激素结合球蛋白以及骨转换标志与骨矿物质密度的关系。
6. Increased bone mineral density in postmenopausal women with type 2 diabetes mellitus [O] . Irzal Hadzibegovic, Blazenka Miskic, Vesna Cosic, 2008

机译：绝经后2型糖尿病女性的骨矿物质密度增加
7. Relationship among plasminogen activator inhibitor-1, bone mineral density, metabolic and bone turnover markers in postmenopausal women with type 2 diabetes mellitus [O] . Silvija Canecki-Varzic, Ines Bilic-Curcic, Ivana Prpic-Krizevac 2015

机译：纤溶酶原激活剂抑制剂-1，绝经后患有2型糖尿病的绝经后妇女骨密度，代谢和骨周转标记的关系

Rosiglitazone Decreases Bone Mineral Density and Increases Bone Turnover in Postmenopausal Women With Type 2 Diabetes Mellitus

摘要

著录项

相似文献

相关主题

期刊订阅